Delivery Order SPE2DB20D2014-SPE2DB23FD43J
- Not listed
- This is a $5,438.08 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Micardis HCT 80-25 mg tablet units, with a completion date of July 16, 2024. There was no set-aside designation used for this award. The contract is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office Division, a major pharmaceutical distributor. The $1,645.38 firm fixed price contract is for the supply of Micardis HCT 80-25 mg tablets in 30-count units. The delivery order is part of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of medical...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The contract is for the supply of 4,565,262,635 units of the pharmaceutical product Micardis HCT 80-25 mg tablet, with a ceiling value of $1,477.48. The award date is July 26, 2024, and the ultimate completion date is July 29, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $1,818.62 to AmerisourceBergen Drug Corp for the supply of MICARDIS HCT 80-25 MG TABLET UD 30S. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare...
- This is a firm fixed price delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution company. The order is for the supply of Micardis HCT 80-12.5 mg tablets, with a potential value of $1,269.08 and a completion date of February 13, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for Micardis HCT 80-25 MG Tablet UD 30S, a cardiovascular medication, with a ceiling value of $3,121.69 and a completion date of May 10, 2023. The contract is part of a broader Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA...
- The U.S. Defense Logistics Agency (DLA) has awarded a $3,358.12 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4,561,813,873 units of the drug Micardis HCT 80-25 mg tablets. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC enables the government to efficiently procure a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,512.01 firm fixed-price delivery order is for the supply of Micardis HCT 40-12.5 mg tablets, a medication used to treat hypertension. The contract has an ultimate completion date of October 28, 2022 and was awarded on October 27, 2022. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
- This is a $1,555.29 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award covers the supply of MICARDIS HCT 80-25 MG TABLET UD 30S, a cardiovascular medication. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,242.18, is for the supply of Micardis HCT 80-12.5 mg tablet medication. The contract is a firm-fixed price delivery order, with a period of performance through November 8, 2024. No set-aside designation was used for this award. In addition to this delivery order, AmerisourceBergen...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB23FD43JDelivery Order
This is a $1,305.09 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Micardis HCT 80-25 mg tablets, with an ultimate completion date of September 25, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order is likely placed against that broader IDC contract. The contract does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 9/22/23 |